These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8937290)

  • 1. White-coat hypertension.
    Verdecchia P; Schillaci G; Borgioni C; Ciucci A; Porcellati C
    Lancet; 1996 Nov; 348(9039):1444-5; author reply 1445-6. PubMed ID: 8937290
    [No Abstract]   [Full Text] [Related]  

  • 2. White-coat hypertension.
    Kristensen KS; Høegholm A
    Lancet; 1996 Nov; 348(9039):1444; author reply 1445-6. PubMed ID: 8937289
    [No Abstract]   [Full Text] [Related]  

  • 3. White-coat hypertension as a cause of cardiovascular dysfunction.
    Glen SK; Elliott HL; Curzio JL; Lees KR; Reid JL
    Lancet; 1996 Sep; 348(9028):654-7. PubMed ID: 8782756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term risk in subjects with white-coat hypertension.
    Obara T; Ohkubo T; Imai Y
    Hypertension; 2009 Nov; 54(5):e133; author reply e134. PubMed ID: 19786645
    [No Abstract]   [Full Text] [Related]  

  • 5. "Masked" and "white-coat" hypertension could signal more serious complications. Experiencing temporary spikes in blood pressure may put you at greater risk of cardiac events.
    Heart Advis; 2009 Nov; 12(11):6. PubMed ID: 21192380
    [No Abstract]   [Full Text] [Related]  

  • 6. [Reverse white-coat hypertension].
    Inenaga T; Kawano Y
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():73-8. PubMed ID: 16981523
    [No Abstract]   [Full Text] [Related]  

  • 7. Short- and long-term risk of cardiovascular events in white-coat hypertension.
    Pierdomenico SD; Lapenna D; Di Mascio R; Cuccurullo F
    J Hum Hypertens; 2008 Jun; 22(6):408-14. PubMed ID: 18288127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular outcome in white-coat versus sustained mild hypertension: a 10-year follow-up study.
    Khattar RS; Senior R; Lahiri A
    Circulation; 1998 Nov; 98(18):1892-7. PubMed ID: 9799210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic importance of white coat and masked hypertension].
    Gustavsen P; Hansen TW
    Ugeskr Laeger; 2009 Jun; 171(24):2019-22. PubMed ID: 19523366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. White-coat hypertension.
    Krakoff LR; Phillips RA
    Lancet; 1996 Nov; 348(9039):1443-4; author reply 1445-6. PubMed ID: 8937288
    [No Abstract]   [Full Text] [Related]  

  • 11. [White coat hypertension].
    Umei H; Matsuoka H; Imaizumi T
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():68-72. PubMed ID: 16981522
    [No Abstract]   [Full Text] [Related]  

  • 12. White-coat hypertension.
    Lim PO; MacFadyen RJ; MacDonald TM
    Lancet; 1996 Nov; 348(9039):1445. PubMed ID: 8937291
    [No Abstract]   [Full Text] [Related]  

  • 13. Predictors for the white coat effect in general practice patients with suspected and treated hypertension.
    Lindbaek M; Sandvik E; Liodden K; Mjell J; Ravnsborg-Gjertsen K
    Br J Gen Pract; 2003 Oct; 53(495):790-3. PubMed ID: 14601355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Masked hypertension and white-coat hypertension: therapeutic navigation between scylla and charybdis.
    Messerli FH; Cotiga D
    J Am Coll Cardiol; 2005 Aug; 46(3):516-7. PubMed ID: 16053967
    [No Abstract]   [Full Text] [Related]  

  • 15. [2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals (summary). Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM)].
    Hermida RC; Smolensky MH; Ayala DE; Portaluppi F; Crespo JJ; Fabbian F; Haus E; Manfredini R; Mojón A; Moyá A; Piñeiro L; Ríos MT; Otero A; Balan H; Fernández JR
    Clin Investig Arterioscler; 2013; 25(2):74-82. PubMed ID: 23849214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White coat effect in treated hypertensive patients: sex differences.
    Myers MG; Reeves RA
    J Hum Hypertens; 1995 Sep; 9(9):729-33. PubMed ID: 8551486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. White coat hypertension is a cardiovascular risk factor: a 10-year follow-up study.
    Gustavsen PH; Høegholm A; Bang LE; Kristensen KS
    J Hum Hypertens; 2003 Dec; 17(12):811-7. PubMed ID: 14704724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of the white-coat effect in hypertensive subjects.
    Mansoor GA; McCabe EJ; White WB
    J Hum Hypertens; 1996 Feb; 10(2):87-92. PubMed ID: 8867561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Measurement and evaluation of blood pressure].
    Inoue R; Ohkubo T; Kikuya M; Imai Y
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():494-7. PubMed ID: 16981583
    [No Abstract]   [Full Text] [Related]  

  • 20. Ambulatory blood pressure monitoring in clinical practice: is being superior good enough?
    Palatini P
    J Hypertens; 2008 Jul; 26(7):1300-2. PubMed ID: 18551000
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.